Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medi-Physics

This article was originally published in The Gray Sheet

Executive Summary

Gains 510(k) clearance for the Iodine-125 RAPID Strand, a delivery system used to implant irradiated 1-125 seeds for the treatment of prostate cancer. The system is comprised of strands of 1-125 seeds encased in absorbable suture material which is implanted into the prostate. The company says RAPID Strand will allow for a more precise placement of seeds into the prostate, thereby increasing the cure rate of this procedure
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003104

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel